Sunday, 11 March 2018 17:42

Chem Rev (2017) - CRISPR/Cas9-based genome editing for disease modeling and therapy: opportunities for non-viral delivery

Written by
Rate this item
(25 votes)
Read 488 times

Leave a comment

Make sure you enter all the required information, indicated by an asterisk (*). HTML code is not allowed.